Moleculin Biotech stock price
NASDAQ:MBRX · Nasdaq · Healthcare · sector #16$6.31+1.94%Oct 21 close · provisional
Loading chart…
Moleculin Biotech's chart data is dated 2026-10-21. There is no active technical signal. The display ticker is MBRX.
Moleculin Biotech last closed at $6.31 (+1.94%) on 2026-10-21. Listed on Nasdaq. Trailing 12 months PER is -1.2×. Its overall grade ranks 717 of 726 stocks in Healthcare.
About this company
Moleculin Biotech last closed at $6.31 (+1.94%) on 2026-10-21. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall F · 717/726
Valuation grade C+
Related stocks
- RocheCompetitor
- Merck & CoCompetitor
- Bristol Myers SquibbCompetitor
About Moleculin Biotech
- What technical signals does Moleculin Biotech (MBRX) have?
- Moleculin Biotech current technical signals: no active technical signal.
- Is Moleculin Biotech a cup-and-handle pattern?
- No. Moleculin Biotech has no valid Cup signal right now.
- What published figures are available for Moleculin Biotech?
- Market cap: $13.04M. Trailing 12 months PER: -1.2×. Latest quarter PBR: 3.03×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about Moleculin Biotech, or open the plan table on the main site.
Ask Q about Moleculin Biotech.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.
Quantus Signal · live data · not investment advice · Privacy Policy